Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TSHR | P16473 | 4/20 | 0.57 |
| ▸ | THRB | P10828 | 1/20 | 0.57 |
| ▸ | DNM1 | Q05193 | 7/20 | 0.42 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.42 |
| ▸ | LMNA | P02545 | 2/20 | 0.42 |
| ▸ | MEN1 | O00255 | 2/20 | 0.42 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.42 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.42 |
| ▸ | SLC22A1 | O15245 | 1/20 | 0.42 |
| ▸ | EPHX1 | P07099 | 1/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL10317806 | 1.00 | TSHR (0.57) | TSHRTHRBDNM1ALDH1A1LMNA | |
| SCHEMBL5318963 | 1.00 | TSHR (0.57) | TSHRTHRBDNM1ALDH1A1LMNA | |
| SCHEMBL3676208 | 1.00 | TSHR (0.57) | TSHRTHRBDNM1ALDH1A1LMNA | |
| SCHEMBL11570870 | 1.00 | TSHR (0.57) | TSHRTHRBDNM1ALDH1A1LMNA | |
| SCHEMBL9066881 | 1.00 | TSHR (0.57) | TSHRTHRBDNM1ALDH1A1LMNA | |
| SCHEMBL11041293 | 1.00 | TSHR (0.57) | TSHRTHRBDNM1ALDH1A1LMNA | |
| SCHEMBL6234379 | 1.00 | TSHR (0.57) | TSHRTHRBDNM1ALDH1A1LMNA | |
| SCHEMBL1562539 | 1.00 | TSHR (0.57) | TSHRTHRBDNM1ALDH1A1LMNA | |
| SCHEMBL152301 | 1.00 | TSHR (0.57) | TSHRTHRBDNM1ALDH1A1LMNA | |
| SCHEMBL11528297 | 1.00 | TSHR (0.57) | TSHRTHRBDNM1ALDH1A1LMNA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1849 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4520722-A1 | SUSTAINABLE ZIEGLER-NATTA CATALYSTS | LANXESS Organometallics GmbH (DE) | 2025-03-12 | — | — | EP | claimed |
| US-20250075012-A1 | Sustainable Ziegler-Natta catalysts | LANXESS ORGANOMETALLICS GMBH (DE) | 2025-03-06 | — | — | US | claimed |
| EP-3440120-B1 | PROCESS AND HYDROCARBON SOLUBLE SALINE HYDRIDE CATALYST FOR HYDROGEN MEDIATED SALINE HYDRIDE INIATED ANIONIC CHAIN TRANSFER POLYMERIZATION AND POLYMER DISTRIBUTION COMPOSITIONS PRODUCED THEREFROM | ALBEMARLE CORP (US) | 2023-11-29 | — | — | EP | claimed |
| CN-115246899-B | Stereoblock polybutadiene and preparation method thereof | 中国石油化工股份有限公司 | 2023-10-10 | — | — | CN | claimed |
| CN-115246913-B | Stereoblock polyisoprene and preparation method thereof | 中国石油化工股份有限公司 | 2023-10-10 | — | — | CN | claimed |
| US-11739170-B2 | Process and hydrocarbon soluble saline hydride catalyst for hydrogen mediated saline hydride initiated anionic chain transfer polymerization and polymer distribution compositions produced therefrom | ALBEMARLE CORPORATION (US) | 2023-08-29 | — | — | US | claimed |
| US-20230192725-A1 | NOVEL ORGANO-MAGNESIUM COMPOUNDS AND THEIR USE | LANXESS ORGANOMETALLICS GMBH (DE) | 2023-06-22 | — | — | US | claimed |
| EP-4153602-A1 | NOVEL ORGANO-MAGNESIUM COMPOUNDS AND THEIR USE | LANXESS Organometallics GmbH (DE) | 2023-03-29 | — | — | EP | claimed |
| CN-115698025-A | Novel organomagnesium compounds and uses thereof | 朗盛奥诺麦特里克斯有限责任公司 | 2023-02-03 | — | — | CN | claimed |
| CN-115246899-A | Stereoblock polybutadiene and preparation method thereof | 中国石油化工股份有限公司 | 2022-10-28 | — | — | CN | claimed |
| EP-0174116-A2 | Polymerization catalyst | EXXON RESEARCH AND ENGINEERING COMPANY (US) | 1986-03-12 | — | — | EP | claimed |
| EP-0170384-A2 | Polymerization catalyst | EXXON RESEARCH AND ENGINEERING COMPANY (US) | 1986-02-05 | — | — | EP | claimed |
| US-4562170-A | Polymerization catalyst | EXXON RESEARCH & ENGINEERING CO. (US) | 1985-12-31 | — | — | US | claimed |
| US-4554265-A | POLYOLEFINS HAVING BROAD MOLECULAR WEIGHT DISTRIBUTION | EXXON RESEARCH & ENGINEERING CO. (US) | 1985-11-19 | — | — | US | claimed |
| EP-0020808-B1 | SUPPORT, CATALYST AND PROCESS FOR POLYMERIZING OLEFINS | THE DOW CHEMICAL COMPANY (US) | 1984-06-27 | — | — | EP | claimed |
| US-4447369-A | REACTING MAGNESIUM WITH ALKYL HALOGENIDE, INCREASE SETTLING WITH CYCLOPENTADIENE COMPOUND | ETHYL CORPORATION (US) | 1984-05-08 | — | — | US | claimed |
| US-4295992-A | Support prepared from organomagnesium compounds and silicon halides; and catalysts for polymerizing olefins | THE DOW CHEMICAL COMPANY (US) | 1981-10-20 | — | — | US | claimed |
| US-4283515-A | Support, catalyst and process for polymerizing olefins | THE DOW CHEMICAL COMPANY (US) | 1981-08-11 | — | — | US | claimed |
| EP-0020808-A1 | Support, catalyst and process for polymerizing olefins | THE DOW CHEMICAL COMPANY (US) | 1981-01-07 | — | — | EP | claimed |
| US-4069267-A | Stable diorganomagnesium compositions | LITHIUM CORPORATION OF AMERICA (US) | 1978-01-17 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230192725-A1 | NOVEL ORGANO-MAGNESIUM COMPOUNDS AND THEIR USE | DDO, MGAM2, MGAM | TSHR 4363/4885THRB 4519/4885DNM1 1041/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.